HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,784,131 | +318.5% | 72,883 | +295.2% | 0.10% | +312.0% |
| Q2 2023 | $665,275 | -59.1% | 18,444 | -56.7% | 0.02% | -63.2% |
| Q1 2023 | $1,627,734 | +66.4% | 42,622 | +91.7% | 0.07% | +88.9% |
| Q2 2022 | $978,000 | +105.9% | 22,232 | +95.0% | 0.04% | +50.0% |
| Q1 2021 | $475,000 | +19.6% | 11,400 | +22.6% | 0.02% | +41.2% |
| Q4 2020 | $397,000 | -26.3% | 9,301 | -54.6% | 0.02% | -32.0% |
| Q3 2020 | $539,000 | +62.3% | 20,500 | +65.3% | 0.02% | +47.1% |
| Q2 2020 | $332,000 | – | 12,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |